|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print August 27, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00247.2002
Submitted on June 6, 2002
Accepted on August 22, 2002
,25(OH)2-Vitamin D3 Inhibits Hepatocyte Growth Factor (HGF) Synthesis and Secretion from MG-63 Human Osteosarcoma Cells
* To whom correspondence should be addressed. E-mail: Naibedya{at}rics.bwh.harvard.edu.
Several mesenchymally derived cells, including osteoblasts, secrete HGF. 1,25
(OH)2-vitamin D3 (1,25D) inhibits proliferation and induces differentiation of MG-63 osteoblastic cells. Here we show that MG-63 cells secrete copious amounts of HGF and that 1,25D inhibits HGF production. MG-63 cells also express HGF receptor (c-Met) mRNA, suggesting an autocrine action of HGF. Indeed, while exogenous HGF failed to stimulate cellular proliferation, neutralizing endogenous HGF with a neutralizing antibody inhibited MG-63 cell proliferation; moreover, inhibiting HGF synthesis with 1,25D followed by addition of HGF rescued hormone-induced inhibition of proliferation. Non-neutralized cells displayed constitutive phosphorylation of c-Met and the MAP kinases MEK1 and Erk1/2, which were inhibited by anti-HGF antibody. Constitutive phosphorylation of Erk1/2 was also abolished by 1,25D. Adding HGF to MG-63 cells treated with neutralizing HGF antibody induced rapid phosphorylation of c-Met, MEK1 and Erk1/2. Thus endogenous HGF induces a constitutively active, autocrine mitogenic loop in MG-63 cells. The known anti-proliferative effect of 1,25D on MG-63 cells can be accounted for by the concomitant 1,25D-induced inhibition of HGF production.
This article has been cited by other articles:
![]() |
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific J. Biol. Chem., November 5, 2004; 279(45): 47298 - 47310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |